ABiMed: An intelligent and visual clinical decision support system for medication reviews and polypharmacy management

• URL: http://arxiv.org/abs/2312.11526v1
• Date: Wed, 13 Dec 2023 11:06:45 GMT
• Title: ABiMed: An intelligent and visual clinical decision support system for medication reviews and polypharmacy management
• Authors: Abdelmalek Mouazer, Romain L\'eguillon, Nada Boudegzdame, Thibaud Levrard, Yoann Le Bars, Christian Simon, Brigitte S\'eroussi, Julien Grosjean, Romain Lelong, Catherine Letord, St\'efan Darmoni, Matthieu Schuers, Karima Sedki, Sophie Dubois, Hector Falcoff, Rosy Tsopra, Jean-Baptiste Lamy
• Abstract summary: The aim of ABiMed is to design an innovative clinical decision support system for medication reviews and polypharmacy management. ABiMed associates several approaches: guidelines implementation, but the automatic extraction of patient data from the GP's electronic health record and its transfer to the pharmacist, and the visual presentation of contextualized drug knowledge using visual analytics.
• Score: 3.843569766201585
• License: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Abstract: Background: Polypharmacy, i.e. taking five drugs or more, is both a public health and an economic issue. Medication reviews are structured interviews of the patient by the community pharmacist, aiming at optimizing the drug treatment and deprescribing useless, redundant or dangerous drugs. However, they remain difficult to perform and time-consuming. Several clinical decision support systems were developed for helping clinicians to manage polypharmacy. However, most were limited to the implementation of clinical practice guidelines. In this work, our objective is to design an innovative clinical decision support system for medication reviews and polypharmacy management, named ABiMed. Methods: ABiMed associates several approaches: guidelines implementation, but the automatic extraction of patient data from the GP's electronic health record and its transfer to the pharmacist, and the visual presentation of contextualized drug knowledge using visual analytics. We performed an ergonomic assessment and qualitative evaluations involving pharmacists and GPs during focus groups and workshops. Results: We describe the proposed architecture, which allows a collaborative multi-user usage. We present the various screens of ABiMed for entering or verifying patient data, for accessing drug knowledge (posology, adverse effects, interactions), for viewing STOPP/START rules and for suggesting modification to the treatment. Qualitative evaluations showed that health professionals were highly interested by our approach, associating the automatic guidelines execution with the visual presentation of drug knowledge. Conclusions: The association of guidelines implementation with visual presentation of knowledge is a promising approach for managing polypharmacy. Future works will focus on the improvement and the evaluation of ABiMed.

Related papers

• A randomized simulation trial evaluating ABiMed, a clinical decision support system for medication reviews and polypharmacy management [3.8243906257653504]
  We designed ABiMed, a clinical decision support system for medication reviews, based on the implementation of the STOPP/START v2 guidelines. We evaluated ABiMed with 39 community pharmacists during a randomized simulation trial.
  arXiv  Detail & Related papers  (2024-09-03T13:50:59Z)
• RuleAlign: Making Large Language Models Better Physicians with Diagnostic Rule Alignment [54.91736546490813]
  We introduce the RuleAlign framework, designed to align Large Language Models with specific diagnostic rules. We develop a medical dialogue dataset comprising rule-based communications between patients and physicians. Experimental results demonstrate the effectiveness of the proposed approach.
  arXiv  Detail & Related papers  (2024-08-22T17:44:40Z)
• Adaptive Behavioral AI: Reinforcement Learning to Enhance Pharmacy Services [2.7180345210658814]
  We introduce a reinforcement learning operational system to deliver personalized behavioral interventions through mobile health applications. We illustrate its potential by discussing a series of initial experiments run with SwipeRx, an all-in-one app for pharmacists.
  arXiv  Detail & Related papers  (2024-08-14T16:18:51Z)
• MedKP: Medical Dialogue with Knowledge Enhancement and Clinical Pathway Encoding [48.348511646407026]
  We introduce the Medical dialogue with Knowledge enhancement and clinical Pathway encoding framework. The framework integrates an external knowledge enhancement module through a medical knowledge graph and an internal clinical pathway encoding via medical entities and physician actions.
  arXiv  Detail & Related papers  (2024-03-11T10:57:45Z)
• PharmacyGPT: The AI Pharmacist [38.247456673883114]
  We introduce PharmacyGPT, a framework to assess the capabilities of large language models (LLMs) in emulating the role of clinical pharmacists. We conduct our investigation using real data acquired from the intensive care unit (ICU) at the University of North Carolina Chapel Hill (UNC) Hospital.
  arXiv  Detail & Related papers  (2023-07-19T19:40:34Z)
• DKINet: Medication Recommendation via Domain Knowledge Informed Deep Learning [12.609882335746859]
  Medication recommendation is a fundamental yet crucial branch of healthcare. Previous studies have primarily focused on learning patient representation from electronic health records. We propose a knowledge injection module that addresses the effective integration of domain knowledge with complex clinical manifestations.
  arXiv  Detail & Related papers  (2023-05-31T07:22:15Z)
• Decision Support System for Chronic Diseases Based on Drug-Drug Interactions [67.9840225237587]
  This paper presents a Decision Support System, called DSSDDI, based on drug-drug interactions to support doctors prescribing decisions. The DDI module learns safer and more effective drug representations from the drug-drug interactions. The MD module considers the representations of patients and drugs as context, DDI and patients' similarity as treatment, and medication use as outcome.
  arXiv  Detail & Related papers  (2023-03-04T12:44:38Z)
• RECOMED: A Comprehensive Pharmaceutical Recommendation System [8.681590862953623]
  A pharmaceutical recommendation system was designed based on the patients and drugs features extracted from Drugs.com and Druglib.com. To the best of our knowledge, we are the first group to consider patients conditions and history in the proposed approach for selecting a specific medicine appropriate for that particular user.
  arXiv  Detail & Related papers  (2022-12-31T20:04:31Z)
• Knowledge-Driven New Drug Recommendation [88.35607943144261]
  We develop a drug-dependent multi-phenotype few-shot learner to bridge the gap between existing and new drugs. EDGE eliminates the false-negative supervision signal using an external drug-disease knowledge base. Results show that EDGE achieves 7.3% improvement on the ROC-AUC score over the best baseline.
  arXiv  Detail & Related papers  (2022-10-11T16:07:52Z)
• Conditional Generation Net for Medication Recommendation [73.09366442098339]
  Medication recommendation targets to provide a proper set of medicines according to patients' diagnoses, which is a critical task in clinics. We propose Conditional Generation Net (COGNet) which introduces a novel copy-or-predict mechanism to generate the set of medicines. We validate the proposed model on the public MIMIC data set, and the experimental results show that the proposed model can outperform state-of-the-art approaches.
  arXiv  Detail & Related papers  (2022-02-14T10:16:41Z)
• Deep learning for drug repurposing: methods, databases, and applications [54.08583498324774]
  Repurposing existing drugs for new therapies is an attractive solution that accelerates drug development at reduced experimental costs. In this review, we introduce guidelines on how to utilize deep learning methodologies and tools for drug repurposing.
  arXiv  Detail & Related papers  (2022-02-08T09:42:08Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.